Reduction of dendritic cells by granulocyte and monocyte adsorption apheresis in patients with ulcerative colitis

G Waitz, S Petermann, S Liebe, J Emmrich… - Digestive diseases and …, 2008 - Springer
The influence of the granulocyte/monocyte apheresis (GMCAP) on cell populations
participating in mechanisms of tolerance, eg dendritic cells (DCs), is still not very clear. In a …

Tumor necrosis factor‐α‐secreting CD16+ antigen presenting cells are effectively removed by granulocytapheresis in ulcerative colitis patients

J Sanchez‐Garcia, J Serrano‐López… - Journal of …, 2010 - Wiley Online Library
Abstract Background and Aim: In human blood, two main subsets of antigen‐presenting‐
cells (APCs) have been described: plasmocytoid dendritic cells (pDC) and myeloid dendritic …

Granulocyte and monocyte adsorption apheresis therapy modulates monocyte‐derived dendritic cell function in patients with ulcerative colitis

Y Iwakami, A Sakuraba, T Sato… - Therapeutic …, 2009 - Wiley Online Library
The aim of this study was to elucidate the molecular mechanisms responsible for the
therapeutic effects of granulocyte and monocyte adsorption apheresis (GMA). We …

[HTML][HTML] Adsorptive granulocyte and monocyte apheresis is effective in ulcerative colitis patients both with and without concomitant prednisolone

K Matsuda, K Ohno, Y Okada, T Yagi… - Inflammatory Intestinal …, 2020 - karger.com
Background: The number of ulcerative colitis (UC) patients is increasing in Japan and other
countries. Selective depletion of myeloid lineage leucocytes by adsorptive granulocyte and …

Clinical and endoscopic features of responders and non-responders to adsorptive leucocytapheresis: a report based on 120 patients with active ulcerative colitis

T Tanaka, H Okanobu, Y Kuga, Y Yoshifuku… - … clinique et biologique, 2010 - Elsevier
BACKGROUND AND OBJECTIVE: Elevated/activated myeloid leucocytes, like the CD14 (+)
CD16 (+) monocytes are sources of TNF-α, and therefore, selective depletion of these cells …

Adsorptive depletion of myeloid lineage leucocytes as remission induction therapy in patients with ulcerative colitis after failure of first-line medications: results from a …

T Iida, K Ikeya, M Kato, J Abe, M Yamamoto… - Digestion, 2017 - karger.com
Background/Aims: In patients with active ulcerative colitis (UC), pharmacologics, although
initially effective in most patients, are associated with refractoriness, loss of response or …

Immunomodulatory effects of granulocyte and monocyte adsorption apheresis as a treatment for patients with ulcerative colitis

N Kashiwagi, K Sugimura, H Koiwai… - Digestive diseases and …, 2002 - Springer
Our aim was to understand the mechanism of immunological changes associated with the
use of an adsorptive-type extracorporeal device (Adacolumn) that has been developed for …

Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled, pilot study

H Hanai, F Watanabe, K Takeuchi, T Iida… - Clinical …, 2003 - Elsevier
Background & Aims: Active ulcerative colitis (UC) is characterized by infiltration of activated
granulocytes and monocytes/macrophages (GM) within the large bowel mucosa. GM are …

Adsorptive granulocyte/monocyte apheresis use in severe ulcerative colitis and determination of changes in plasma cytokines

B Beltran, E Sáez‐González, I Moret… - Journal of clinical …, 2018 - Wiley Online Library
Despite controversy regarding the use of granulocyte/monocyte adsorption (GMA) in
inflammatory bowel disease, some studies have shown favorable outcomes when it is used …

Intensive granulocyte and monocyte adsorption versus intravenous prednisolone in patients with severe ulcerative colitis: an unblinded randomised multi-centre …

H Hanai, T Iida, K Takeuchi, F Watanabe… - Digestive and Liver …, 2008 - Elsevier
BACKGROUND AND AIM: Several uncontrolled studies have reported on the efficacy of
adsorptive depletion of peripheral blood granulocytes and monocytes/macrophages (GMA) …